Cancer screening resident survival guide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]
Overview
This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.
Common Cancers
Breast Cancer
- Breast cancer screening starts at age ..... via [imaging].
- To view the detailed information on breast cancer screening click here.
Cervical Cancer
Colorectal Cancer
- Colorectal cancer screening starts among asymptomatic adults at the age of 50 with no family history of adenoma or colorectal cancer. It is preferably done via colonoscopy[1]
- According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, Colon cancer is the fourth commonly occurring cancer (6.1% for incidence). It is the third cause of death in cancer patients (9.2% for mortality).[2]
- To view the detailed information on colorectal cancer screening click here.
Endometrial Cancer
Esophageal Cancer
Lung Cancer
- Lung cancer screening starts among asymptomatic adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit smoking within the past 15 years.
- According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, Lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths).[2]
- To view the detailed information on Lung cancer screening click here.
Ovarian cancer
Prostate Cancer
- ↑ US Preventive Services Task Force. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW; et al. (2016). "Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement". JAMA. 315 (23): 2564–2575. doi:10.1001/jama.2016.5989. PMID 27304597.
- ↑ 2.0 2.1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018). "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries". CA Cancer J Clin. 68 (6): 394–424. doi:10.3322/caac.21492. PMID 30207593.